Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK.
Victorian Clinical Genetics Services, The Royal Children's Hospital, Melbourne, Australia.
ESMO Open. 2021 Aug;6(4):100199. doi: 10.1016/j.esmoop.2021.100199. Epub 2021 Jul 1.
The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology.
This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measures including well-being/distress (expanded Well-being Index-9 items), burnout (1 item from expanded Well-being Index), and job performance since COVID-19 were tracked.
A total of 942 participants from 99 countries were included for final analysis: 58% (n = 544) from Europe, 52% (n = 485) female, 43% (n = 409) ≤40 years old, and 36% (n = 343) of non-white ethnicity. In July/August 2020, 60% (n = 525) continued to report a change in professional duties compared with the pre-COVID-19 era. The proportion of participants at risk of poor well-being (33%, n = 310) and who reported feeling burnout (49%, n = 460) had increased significantly compared with April/May 2020 (25% and 38%, respectively; P < 0.001), despite improved job performance since COVID-19 (34% versus 51%; P < 0.001). Of those who had been tested for COVID-19, 8% (n = 39/484) tested positive; 18% (n = 7/39) felt they had not been given adequate time to recover before return to work. Since the pandemic, 39% (n = 353/908) had expressed concerns that COVID-19 would have a negative impact on their career development or training and 40% (n = 366/917) felt that their job security had been compromised. More than two-thirds (n = 608/879) revealed that COVID-19 has changed their outlook on their work-personal life balance.
The COVID-19 pandemic continues to impact the well-being of oncology professionals globally, with significantly more in distress and feeling burnout compared with the first wave. Collective efforts from both national and international communities addressing support and coping strategies will be crucial as we recover from the COVID-19 crisis. In particular, an action plan should also be devised to tackle concerns raised regarding the negative impact of COVID-19 on career development, training, and job security.
COVID-19 大流行导致全球肿瘤学专业人员的职业和个人生活发生重大变化。欧洲肿瘤内科学会(ESMO)弹性工作组的合作旨在提供关于 COVID-19 对肿瘤学领域生活体验和健康的影响的当代报告。
这是一项在线匿名调查(2020 年 7 月至 8 月),是大流行期间发起的一系列全球调查中的第二项。长期关键的结果指标包括幸福感/压力(扩展的幸福感指数-9 项)、倦怠(扩展的幸福感指数中的 1 项)和 COVID-19 以来的工作表现。
共有来自 99 个国家的 942 名参与者纳入最终分析:58%(n=544)来自欧洲,52%(n=485)为女性,43%(n=409)年龄≤40 岁,36%(n=343)为非白种人。2020 年 7 月/8 月,60%(n=525)与 COVID-19 前时代相比,继续报告专业职责发生变化。与 2020 年 4 月/5 月相比,报告幸福感不佳(33%,n=310)和感到倦怠(49%,n=460)的参与者比例显著增加(分别为 38%和 38%;P<0.001),尽管 COVID-19 以来的工作表现有所改善(34%比 51%;P<0.001)。在接受 COVID-19 检测的人群中,8%(n=39/484)检测呈阳性;18%(n=7/39)表示在返回工作岗位之前没有得到足够的时间来恢复。自大流行以来,39%(n=353/908)表示担心 COVID-19 会对他们的职业发展或培训产生负面影响,40%(n=366/917)认为他们的工作保障受到了损害。超过三分之二(n=608/879)表示 COVID-19 改变了他们对工作与个人生活平衡的看法。
COVID-19 大流行继续影响全球肿瘤学专业人员的健康,与第一波相比,压力更大,倦怠感更严重。国家和国际社会共同努力,提供支持和应对策略将至关重要,因为我们正在从 COVID-19 危机中恢复。特别是,还应该制定一个行动计划,以解决有关 COVID-19 对职业发展、培训和工作保障产生负面影响的担忧。